Clinical Trial Update: A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial to assess the efficacy and safety of Vutiglabridin in patients with early Parkinson disease, and it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Vutiglabridin (Vutiglabridin)

Snippet

Sponsor: Glaceum | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING